Mirrored from Robert W Malone MD, 27-9-2021 (25min). RelCovaxTM, a second-generation multivalent SARS-CoV-2 vaccine candidate designed to meet global vaccination demands.
Presenter: Robert W Malone, Vaccines and Biotechnology,
For: Reliancer Life Sciences
RW Malone MD, LLC: Consultancy and Analytics in the Biosector